MorphoSys AG
MPSYFOTCHealthcare
$73.27
+$1.51(+2.10%)
Market Cap$2.8B
P/E Ratio—
52W High$73.27
52W Low$25.56
MorphoSys AG (MPSYF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MPSYF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 29, 2024EPS Actual
-$2.26
Est. -$1.33 · -70.2%
Revenue
$0.04B
Est. $0.03B · +18.5%
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 29, 2024
After Market Close
▼ Miss EPS▲ Beat Revenue
MPSYF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $1.10B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$1.10B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 27, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | Apr 28, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 11, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Oct 30, 2024 | — | — | — | — | — | — |
| ▼ Q3 FY2024 | Aug 29, 2024 | -$1.33 | -$2.26 | -70.2% | $0.04B | $0.03B | +18.5% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -$1.22 | -$8.99 | -638.4% | $0.03B | $0.06B | -49.6% |
| ▲ Q1 FY2024 | Mar 13, 2024 | -$2.07 | $1.34 | +164.7% | $0.06B | $0.07B | -0.9% |
| ▼ Q4 FY2023 | Nov 16, 2023 | -$2.25 | -$3.69 | -63.9% | $0.07B | $0.06B | +12.2% |
Q3 FY2025
Aug 27, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 30, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 29, 2024Miss
EPS Actual
-$2.26
EPS Est.
-$1.33
EPS Surpr.
-70.2%
Revenue
$0.04B
Q2 FY2024
Apr 29, 2024Miss
EPS Actual
-$8.99
EPS Est.
-$1.22
EPS Surpr.
-638.4%
Revenue
$0.03B
Q1 FY2024
Mar 13, 2024Beat
EPS Actual
$1.34
EPS Est.
-$2.07
EPS Surpr.
+164.7%
Revenue
$0.06B
Q4 FY2023
Nov 16, 2023Miss
EPS Actual
-$3.69
EPS Est.
-$2.25
EPS Surpr.
-63.9%
Revenue
$0.07B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $-0.64 | $-0.64 | $-0.64 | 1 |
| Q4 FY2024 | $-0.86 | $-0.86 | $-0.86 | 1 |
| Q3 FY2024 | $-1.02 | $-1.02 | $-1.02 | 1 |
| Q2 FY2024 | $-1.24 | $-1.24 | $-1.24 | 1 |
| Q1 FY2024 | $-1.13 | $-1.13 | $-1.13 | 1 |
| Q4 FY2023 | $-1.88 | $-1.88 | $-1.88 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2023 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Aug 29, 2024 | -70.2% | $73.27 | $73.27 | +0.00% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -638.4% | $71.38 | $72.38 | +1.40% |
| ▲ Q1 FY2024 | Mar 13, 2024 | +164.7% | $72.71 | $71.38 | -1.83% |
| ▼ Q4 FY2023 | Nov 16, 2023 | -63.9% | $31.55 | $20.15 | -36.13% |
| ▲ Q3 FY2023 | Aug 10, 2023 | +69.4% | $30.18 | $28.06 | -7.02% |
| ▲ Q2 FY2023 | May 4, 2023 | +84.0% | $20.77 | $24.05 | +15.79% |
| ▲ Q1 FY2023 | Mar 15, 2023 | +718.5% | $17.29 | $18.14 | +4.92% |
| ▼ Q4 FY2022 | Nov 16, 2022 | -138.4% | No price data | $15.20 | — |
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
-70.2%
Price Before
$73.27
Price After
$73.27
Q2 FY2024+1.40%
Report Date
Apr 29, 2024
EPS Beat/Miss
-638.4%
Price Before
$71.38
Price After
$72.38
Q1 FY2024-1.83%
Report Date
Mar 13, 2024
EPS Beat/Miss
+164.7%
Price Before
$72.71
Price After
$71.38
Q4 FY2023-36.13%
Report Date
Nov 16, 2023
EPS Beat/Miss
-63.9%
Price Before
$31.55
Price After
$20.15
Q3 FY2023-7.02%
Report Date
Aug 10, 2023
EPS Beat/Miss
+69.4%
Price Before
$30.18
Price After
$28.06
Q2 FY2023+15.79%
Report Date
May 4, 2023
EPS Beat/Miss
+84.0%
Price Before
$20.77
Price After
$24.05
Q1 FY2023+4.92%
Report Date
Mar 15, 2023
EPS Beat/Miss
+718.5%
Price Before
$17.29
Price After
$18.14
Q4 FY2022—
Report Date
Nov 16, 2022
EPS Beat/Miss
-138.4%
Price Before
—
Price After
$15.20
Avg Beat Reaction+2.96%
Avg Miss Reaction-11.58%
Beat Rate4 / 8 quarters
Largest Move-36.13% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MPSYF ends December
MorphoSys AG (MPSYF) most recently reported earnings on August 29, 2024 for Q3 FY2024, posting EPS of $-2.26 — missing the analyst consensus of $-1.33 by -70.2%. The next MPSYF earnings date is expected around September 1, 2026.
Each quarter, investors track MPSYF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MPSYF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MPSYF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MPSYF earnings · 5 questionsMorphoSys AG's next earnings report is expected around September 1, 2026. MPSYF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MPSYF historically reports after market close (AMC).
MPSYF earnings datewhen is MPSYF earningsMPSYF next earnings datewhen does MPSYF report earningsMPSYF earnings calendar
▸ Source: FMP · MorphoSys AG SEC filings · US GAAP · MorphoSys AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026